(Q44656924)

5 December 2017

Differential geographical risk of initial Pseudomonas aeruginosa acquisition in young US children with cystic fibrosis (English)

1 reference

5 December 2017

0 references

Pseudomonas aeruginosa

1 reference

3

Anneclaire J De Roos

1 reference

5 December 2017

Kevin J Psoter

1

1 reference

5 December 2017

Margaret Rosenfeld

series ordinal

2

1 reference

5 December 2017

Jonathan D Mayer

series ordinal

4

1 reference

5 December 2017

Jon Wakefield

series ordinal

5

1 reference

5 December 2017

language of work or name

English

0 references

publication date

29 May 2014

1 reference

American Journal of Epidemiology

5 December 2017

1 reference

5 December 2017

179

1 reference

5 December 2017

1503-1513

1 reference

5 December 2017

12

1 reference

Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis.

5 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Effects of pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Eradication of early Pseudomonas aeruginosa infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

The phenotypic consequences of CFTR mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Bayesian image restoration, with two applications in spatial statistics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Bayesian inference for generalized linear mixed models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Disease mapping and spatial regression with count data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

Geography, ecology and emerging infectious diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU077

21 January 2018

Identifiers

DOI

10.1093/AJE/KWU077

1 reference

5 December 2017

1 reference